Drug discovery
Computational drug discovery for the Zika virus
10
Contribution to drug discovery and development for tauopathies using yeast as a model
259
From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases
17
<it>ADDME – Avoiding Drug Development Mistakes Early</it>: central nervous system drug discovery perspective
4
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
11
SWEETLEAD: an in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery.
9
Strategies towards expansion of chemical space of natural product‑based compounds to enable drug discovery
16
Metabolomics and Its Potential in Drug Discovery and Development From TCM
7
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
7
A new in vivo screening paradigm to accelerate antimalarial drug discovery.
12
The next opportunity in anti-malaria drug discovery: the liver stage.
5
Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery.
16
High throughput screening for anti-Trypanosoma cruzi drug discovery.
6
Drug discovery and computational strategies in the multitarget drugs era
25
Open source drug discovery in practice: a case study.
11
CURRENT TRENDS IN DRUG DISCOVERY: TARGET IDENTIFICATION TO CLINICAL DEVELOPMENT OF THE DRUG
5
SYNTHETIC STRATEGIES IN DRUG DISCOVERY: EMPLOYNG DIVERSITY-ORIENTED SYNTHESIS.
12
Improving the drug discovery process by using multiple classifier systems
34
Easy Bioinformatics Analysis (EBiAn): a package for manipulating and analysis of short biological sequences
3
Braz. J. Pharm. Sci. vol.53 número2
7